Model accurately predicts hepatocellular carcinoma among patients with HCV-related cirrhosis with SVR to DAAs.

Researchers investigated whether leptin, as a marker of adiposity, could be a link between advanced prostate cancer and coronary heart disease.

Despite treatment advancements with the introduction of HDMTX and rituximab, up to half of patients will have disease relapse, and 10%–15% may have primary refractory disease.

Bowel side effects do not differ between patients with localized prostate cancer who receive external beam radiation therapy using protons vs photons, investigators reported in a late-breaking ...

The researchers assessed TROP2 expression in 19 patient samples and found that 52% had high TROP2 expression (H-score ≥100; mean 123.6±90; range, 0-248). A post hoc analysis showed that OS positively ...

Intervention participants were more likely to complete screening and to have detection of advanced colorectal neoplasia.

Fedratinib can reduce symptoms and spleen volume in patients with myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), according to research presented at the ASH ...

Enfortumab vedotin may be a treatment option for patients with advanced head and neck cancer that is not amenable to definitive local therapy, researchers say. They reported phase 2 results with ...

Researchers sought to determine whether it would be beneficial to add inotuzumab to the CALGB 10403 pediatric regimen in the treatment of young adults with CD22-positive B-ALL.

IFRT only needs to be considered for PET-negative patients at high risk of recurrence, according to John Radford, MD.

Breast cancer prevention efforts should include population-wide policies and regulations to reduce air pollution, according to researchers.

Lower cumulative incidence reported for two-year physician-scored toxicity and late-grade ≥2 toxicity with MRI guidance.